Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
8.56
-0.18 (-2.06%)
At close: Apr 28, 2026, 4:00 PM EDT
8.73
+0.17 (1.99%)
After-hours: Apr 28, 2026, 4:19 PM EDT
Eikon Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Selling, General & Admin | 67.11 | 55.81 | 58.48 |
| Research & Development | 247.32 | 204.54 | 207.26 |
| Operating Expenses | 314.43 | 260.34 | 265.74 |
| Operating Income | -314.43 | -260.34 | -265.74 |
| Interest Expense | -0.84 | -0.03 | -0.04 |
| Interest & Investment Income | 15.57 | 16.56 | 23.74 |
| Other Non Operating Income (Expenses) | -0.03 | -0 | 0.04 |
| EBT Excluding Unusual Items | -299.73 | -243.81 | -242 |
| Merger & Restructuring Charges | -3.29 | - | - |
| Asset Writedown | -21.23 | - | - |
| Pretax Income | -324.25 | -243.81 | -242 |
| Net Income | -324.25 | -243.81 | -242 |
| Preferred Dividends & Other Adjustments | 9.4 | - | - |
| Net Income to Common | -333.64 | -243.81 | -242 |
| Shares Outstanding (Basic) | 3 | 3 | 2 |
| Shares Outstanding (Diluted) | 3 | 3 | 2 |
| Shares Change (YoY) | 14.85% | 24.35% | - |
| EPS (Basic) | -115.29 | -96.76 | -119.43 |
| EPS (Diluted) | -115.29 | -96.76 | -119.43 |
| Free Cash Flow | -235.26 | -219.6 | -219.36 |
| Free Cash Flow Per Share | -81.29 | -87.16 | -108.26 |
| EBITDA | -295.55 | -245.34 | -254.31 |
| D&A For EBITDA | 18.87 | 15.01 | 11.43 |
| EBIT | -314.43 | -260.34 | -265.74 |
Source: S&P Capital IQ. Standard template.
Financial Sources.